Revised intimation of Change in Management with minor correction in cover letter
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has announced the re-appointment of two key directors. Dr. Mukund Gurjar is re-appointed as Whole-time Director for 1 year from August 28, 2026, and Mr. Satish Mehta is re-appointed as Managing Director for 5 years from April 01, 2027. Both appointments are subject to shareholder approval. Dr. Gurjar has been with the company since 2001 and serves as Chief Scientific Officer. Mr. Satish Mehta is the founder and current Managing Director & CEO. The document also notes that Mr. Satish Mehta is father to two other Whole-time Directors on the board.
This is a routine board continuity announcement. Existing leadership remains in place, which provides stability for shareholders. The re-appointments require shareholder approval but are expected to proceed smoothly.